Tandem Diabetes Care, Inc.

Operating company

Corporate group: Tandem Diabetes Care Group · HQ: United States

Total cases

Claimant-side

Respondent-side

Tandem Diabetes Care, Inc. has been party to 18 Unified Patent Court cases, 9 times as claimant and 9 times as respondent. The most recent on record is UPC CoA 120/2025 at the Court of Appeal, against Roche Diabetes Care GmbH. Its most recent decision on the merits was in UPC CFI 454/2023 at the Paris Central Division on 18 December 2024: patent upheld as granted.

Top opponents

Roche Diabetes Care GmbH17

More opponents

Top firms

Kather Augenstein17

More firms

Start 14-day free trialEvery opponent and every firm acting for and against Tandem Diabetes Care, Inc..Already a user? Sign in

Recent cases

View all cases

2025-02-17UPC CoA 120/2025Court of AppealSettledTandem Diabetes Care Europe B.V. v Roche Diabetes Care GmbH
2025-01-20UPC CFI 11/2025Paris CDCosts onlyRoche Diabetes Care GmbH v Tandem Diabetes Care, Inc.
2024-04-19CC 20972/2024Dusseldorf LD—Rubin Medical ApS v F. Hoffmann-La Roche AG
2024-02-29UPC CFI 88/2024Hamburg LDSettledRoche Diabetes Care GmbH v Tandem Diabetes Care, Inc.
2024-01-02UPC CFI 504/2023Dusseldorf LDSettledF. Hoffmann-La Roche AG v Tandem Diabetes Care, Inc.
2023-11-30UPC CFI 454/2023Paris CDPatent upheld as grantedTandem Diabetes Care, Inc. v Roche Diabetes Care GmbH
2023-11-30UPC CFI 455/2023Paris CDSettledTandem Diabetes Care, Inc. v Roche Diabetes Care GmbH
—UPC APP 11294/2025Dusseldorf LDProcedural onlyF. Hoffmann-La Roche AG v Tandem Diabetes Care, Inc.
—UPC APP 23079/2025Dusseldorf LDProcedural onlyF. Hoffmann-La Roche AG v Tandem Diabetes Care, Inc.
—UPC APP 28226/2025Dusseldorf LDProcedural onlyF. Hoffmann-La Roche AG v Tandem Diabetes Care, Inc.